143 related articles for article (PubMed ID: 15115417)
1. Prevention of recurrent thrombosis in the antiphospholipid antibody syndrome: how long and how high with oral anticoagulant therapy?
Baker RI
Med J Aust; 2004 May; 180(9):436-7. PubMed ID: 15115417
[No Abstract] [Full Text] [Related]
2. Evidence-based management of thrombosis in the antiphospholipid antibody syndrome.
Petri M
Curr Rheumatol Rep; 2003 Oct; 5(5):370-3. PubMed ID: 12967519
[TBL] [Abstract][Full Text] [Related]
3. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H
Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460
[TBL] [Abstract][Full Text] [Related]
4. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
[TBL] [Abstract][Full Text] [Related]
5. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.
Ruiz-Irastorza G; Khamashta MA; Hunt BJ; Escudero A; Cuadrado MJ; Hughes GR
Arch Intern Med; 2002 May; 162(10):1164-9. PubMed ID: 12020188
[TBL] [Abstract][Full Text] [Related]
6. The management of thrombosis in the antiphospholipid-antibody syndrome.
Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid Syndrome On Cloud (APSOnCloud): web-based monitoring of oral anticoagulation.
Nogueira F; Signorelli F; Levy RA
Lupus; 2017 Feb; 26(2):179-185. PubMed ID: 27436335
[TBL] [Abstract][Full Text] [Related]
8. Variability in the international normalised ratio (INR) in patients with antiphospholipid syndrome and positive lupus anticoagulant: should the INR targets be higher?
Baquero-Salamanca M; Téllez-Arévalo AM; Calderon-Ospina C
BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25858939
[TBL] [Abstract][Full Text] [Related]
9. Warfarin prophylaxis in the antiphospholipid antibody syndrome.
Stern SD
N Engl J Med; 2003 Dec; 349(26):2568-70; author reply 2568-70. PubMed ID: 14699650
[No Abstract] [Full Text] [Related]
10. Management of antiphospholipid antibody syndrome: a systematic review.
Lim W; Crowther MA; Eikelboom JW
JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
[TBL] [Abstract][Full Text] [Related]
11. Cessation of oral anticoagulants in antiphospholipid syndrome.
Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P
Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome.
Ohnishi N; Fujieda Y; Hisada R; Nakamura H; Kato M; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
Rheumatology (Oxford); 2019 Jun; 58(6):969-974. PubMed ID: 30508199
[TBL] [Abstract][Full Text] [Related]
13. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
Rickles FR; Marder VJ
J Thromb Haemost; 2005 May; 3(5):842-3. PubMed ID: 15869572
[No Abstract] [Full Text] [Related]
14. [Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].
Kondrat'eva LV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Kovalenko TF; Ostriakova EV; Reshetniak TM
Ter Arkh; 2010; 82(5):33-9. PubMed ID: 20597268
[TBL] [Abstract][Full Text] [Related]
15. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.
Dufrost V; Risse J; Zuily S; Wahl D
Curr Rheumatol Rep; 2016 Dec; 18(12):74. PubMed ID: 27812956
[TBL] [Abstract][Full Text] [Related]
16. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
Khamashta MA; Hunt BJ
J Thromb Haemost; 2005 May; 3(5):844-5. PubMed ID: 15869573
[No Abstract] [Full Text] [Related]
17. [Aspirin and antiphospholipid syndrome].
Hachulla E; Piette AM; Hatron PY; Blétry O
Rev Med Interne; 2000 Mar; 21 Suppl 1():83s-88s. PubMed ID: 10763209
[TBL] [Abstract][Full Text] [Related]
18. Intensity of anticoagulation in the treatment of thrombosis in the antiphospholipid syndrome: a meta-analysis.
Silva FF; Carvalho JF
Rev Bras Reumatol; 2015; 55(2):159-66. PubMed ID: 25440707
[TBL] [Abstract][Full Text] [Related]
19. Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome.
Ames PR; Margaglione M; Ciampa A; Colaizzo D; Ferrara F; Iannaccone L; Vincenzobrancaccio
Thromb Res; 2011 Jun; 127(6):595-9. PubMed ID: 21371740
[TBL] [Abstract][Full Text] [Related]
20. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? Yes.
Scully MF
J Thromb Haemost; 2005 May; 3(5):840-1. PubMed ID: 15869571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
